Related Experiment Video
Updated: Jun 28, 2026

A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
Dramatic effect of a somatostatin analogue in decreasing mucus production by the intestinal segment after
Mohammad-Hatef Khorrami1, Peyman Salehi, Kia Nouri-Mahdavi
1Department of Urology, Isfahan University of Medical Sciences, Isfahan, Iran. khorami@med.mui.ac.ir
Purpose:
Catheter obstruction from mucus plugging and urinary leakage are common problems after enterocystoplasty. A large suprapubic catheter and frequent bladder irrigation with normal saline are routinely used in the postoperative period to decrease catheter plugging. In this study we evaluated the use of a somatostatin analogue (Sandostatin to decrease mucus production by the intestinal segment after enterocystoplasty.
Materials And Methods:
We performed enterocystoplasty using ileal segments (20 to 30 cm) in 40 patients. In 20 patients Sandostatin (0.05 mg subcutaneously) was started 1 hour before the procedure and was then administered every 8 hours for 15 days. Bladder irrigation was performed whenever drainage from the suprapubic catheter caused blockage. The drain was removed 24 to 48 hours after the resumption of oral feeding if urine leakage was insignificant. We then compared the number of bladder irrigations required, mucus volume, time to remove the drain and hospital stay between the groups.
Results:
Only 5 patients in the treatment group required bladder irrigation. The mean number of bladder irrigations for each patient was 0.35 +/- 0.67 in the group receiving Sandostatin and 10.35 +/- 2.13 for the control group (p <0.001). Mean mucus volumes on postoperative day 3 were 4.42 +/- 1.95 and 42.5 +/- 5.14 ml in the treatment and control groups, respectively (p <0.001). Mean time to remove the drain was 6.35 days for the Sandostatin group and 6.8 days for the control group. Mean hospital stay was 7.4 and 7.9 days for the treatment and control groups, respectively (p <0.05).
Conclusions:
Sandostatin caused a marked decrease in mucus production by the intestinal segment with patients receiving Sandostatin no longer requiring routine postoperative bladder irrigation and having a shorter hospital stay.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
